STOCK TITAN

NovaBridge Biosciences (NBP) Net Income by Year

NBP NASDAQ

NovaBridge Biosciences reported a net loss of $46.3M in fiscal year 2025. The change from the prior fiscal year is not meaningful, because that figure was zero or negative. The table below carries 7 fiscal years, from 2019 to 2025, and the quarters NovaBridge Biosciences has filed alongside them.

FY2025 annual
Net Income -$46.3M
YoY n/m
Source SEC Filings (20-F/6-K) Latest period FY2025, ended Dec 31, 2025 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

NBP Net Income by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricFY2520-FFY2420-FFY2320-FFY2220-FFY2120-FFY2020-FFY1920-F
Net Income-$46.3Mn/m-$22.2Mn/m-$207.7Mn/m-$371.1Mn/m-$365.9M-607.0%$72.2Mn/m-$208.6M

NBP Net Income by Quarter

Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ4'2520-FQ3'256-KQ2'256-KQ4'2420-FQ3'246-KQ4'2320-FQ4'2220-FQ2'226-KQ4'2120-FQ4'2020-FQ3'206-KQ4'1920-F
Net IncomeN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A

What net income means

Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line.

More NovaBridge Biosciences financials

Frequently Asked Questions

What was NovaBridge Biosciences's net income in fiscal year 2025?

NovaBridge Biosciences reported a net loss of $46.3M in fiscal year 2025.

How fast is NovaBridge Biosciences's net income growing?

NovaBridge Biosciences (NBP) reported a $22.2M net loss in fiscal year 2024 and a $46.3M net loss in fiscal year 2025. A growth rate is not meaningful here, because the earlier figure was zero or negative.

How has NovaBridge Biosciences's net income changed over the years?

Across the 7 fiscal years this page covers, NovaBridge Biosciences (NBP) net income went from -$208.6M in fiscal year 2019 to -$46.3M in fiscal year 2025.

Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line. This page lists what NovaBridge Biosciences (NBP) reported on that line in every period on record.